City

Boston (2)

Condition

Chronic Lymphocytic Leukemia (2)

Small Lymphocytic Leukemia (2)

Overall Status

Active, not recruiting (1)

Terminated (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Dana-Farber Cancer Institute (2)

Collaborator

Beth Israel Deaconess Medical Center (2)

Brigham and Women's Hospital (2)

Celgene Corporation (1)

Lymphoma Research Foundation (1)

Massachusetts General Hospital (1)

Intervention

fludarabine (1)

lenalidomide (1)

pyrimethamine (1)

rituximab (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

Small Lymphocytic Leukemia

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in Boston (pyrimethamine)

Active, not recruiting

Has Results

Chronic Lymphocytic Leukemia
Small Lymphocytic Leukemia

pyrimethamine

Boston, Massachusetts
+1 more

Nov 14, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in Boston (Lenalidomide, Fludarabine, Rituximab)

Terminated

Chronic Lymphocytic Leukemia
Small Lymphocytic Leukemia

Lenalidomide
+2 more

Boston, Massachusetts
+1 more

May 26, 2016